BioMaxima S.A. (WSE: BMX)
Poland
· Delayed Price · Currency is PLN 14.75
+0.45 (3.15%)
Sep 27, 2024, 5:00 PM CET
BioMaxima Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 47.24 | 46.79 | 143.87 | 79.09 | 61.28 | 30.61 | Upgrade
|
| Revenue Growth (YoY) | -22.99% | -67.48% | 81.91% | 29.06% | 100.19% | -4.40% | Upgrade
|
| Cost of Revenue | 24.93 | 25.11 | 87.86 | 48.94 | 37.74 | 17.66 | Upgrade
|
| Gross Profit | 22.31 | 21.68 | 56.01 | 30.15 | 23.55 | 12.95 | Upgrade
|
| Selling, General & Admin | 18.57 | 18.22 | 17.49 | 15.29 | 11.85 | 10.02 | Upgrade
|
| Other Operating Expenses | 1.14 | 0.95 | 1.67 | -0.39 | 0.47 | 0.48 | Upgrade
|
| Operating Expenses | 22.34 | 21.48 | 21.11 | 16.49 | 14.17 | 12.18 | Upgrade
|
| Operating Income | -0.03 | 0.2 | 34.9 | 13.65 | 9.38 | 0.77 | Upgrade
|
| Interest Expense | -0.71 | -0.61 | -0.48 | -0.2 | -0.34 | -0.45 | Upgrade
|
| Interest & Investment Income | 0.24 | 0.14 | 0.8 | - | 0.1 | 0.07 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.2 | -0.2 | -0.01 | -0.06 | -0.2 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.7 | 0.77 | 0.69 | -0.67 | -0.03 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | 0 | 0.3 | 35.9 | 12.72 | 8.91 | 0.33 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -0.05 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | -0 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0 | 0.06 | 0.11 | 0.02 | Upgrade
|
| Asset Writedown | -0.08 | -0.13 | -0.03 | - | 0.55 | -0.11 | Upgrade
|
| Pretax Income | -0.06 | 0.19 | 35.87 | 12.78 | 9.57 | 0.18 | Upgrade
|
| Income Tax Expense | -0.42 | -0.4 | 6.98 | 2.53 | 1.62 | 0.17 | Upgrade
|
| Earnings From Continuing Operations | 0.36 | 0.59 | 28.89 | 10.24 | 7.95 | 0.01 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | -0.03 | Upgrade
|
| Net Income | 0.36 | 0.59 | 28.89 | 10.24 | 7.95 | -0.01 | Upgrade
|
| Net Income to Common | 0.36 | 0.59 | 28.89 | 10.24 | 7.95 | -0.01 | Upgrade
|
| Net Income Growth | -93.01% | -97.97% | 182.00% | 28.86% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | -3.64% | -3.16% | -0.52% | 4.44% | 15.05% | - | Upgrade
|
| EPS (Basic) | 0.08 | 0.14 | 6.68 | 2.37 | 1.93 | -0.00 | Upgrade
|
| EPS (Diluted) | 0.08 | 0.14 | 6.48 | 2.29 | 1.85 | -0.00 | Upgrade
|
| EPS Growth | -92.77% | -97.91% | 182.97% | 23.78% | - | - | Upgrade
|
| Free Cash Flow | -11.16 | -16.49 | 27.19 | -4.61 | 2.09 | 3.29 | Upgrade
|
| Free Cash Flow Per Share | -2.61 | -3.82 | 6.10 | -1.03 | 0.49 | 0.88 | Upgrade
|
| Dividend Per Share | 0.390 | 0.390 | 0.500 | 0.450 | 0.250 | - | Upgrade
|
| Dividend Growth | -22.00% | -22.00% | 11.11% | 80.00% | - | - | Upgrade
|
| Gross Margin | 47.23% | 46.34% | 38.93% | 38.12% | 38.42% | 42.32% | Upgrade
|
| Operating Margin | -0.07% | 0.43% | 24.26% | 17.26% | 15.30% | 2.53% | Upgrade
|
| Profit Margin | 0.76% | 1.25% | 20.08% | 12.95% | 12.97% | -0.04% | Upgrade
|
| Free Cash Flow Margin | -23.63% | -35.24% | 18.90% | -5.83% | 3.41% | 10.75% | Upgrade
|
| EBITDA | 2.51 | 2.47 | 36.64 | 15.1 | 10.94 | 2.18 | Upgrade
|
| EBITDA Margin | 5.32% | 5.29% | 25.47% | 19.09% | 17.85% | 7.12% | Upgrade
|
| D&A For EBITDA | 2.54 | 2.27 | 1.74 | 1.45 | 1.56 | 1.4 | Upgrade
|
| EBIT | -0.03 | 0.2 | 34.9 | 13.65 | 9.38 | 0.77 | Upgrade
|
| EBIT Margin | -0.07% | 0.43% | 24.26% | 17.26% | 15.30% | 2.53% | Upgrade
|
| Effective Tax Rate | - | - | 19.47% | 19.82% | 16.90% | 92.29% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 30.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.